Publication Author: Basu_Anirban

• Difficulty with Taking Medications Is Associated with Future Diagnosis of Alzheimer’s Disease and Related Dementias.

  Barthold D, Marcum ZA, Chen S, White L, Ailabouni N, Basu A, Coe NB, Gray SL. Difficulty with Taking Medications Is Associated with Future Diagnosis of Alzheimer’s Disease and Related Dementias. J Gen Intern Med. 2021 Apr;36(4):863-868. doi: 10.1007/s1160

  rakerr2

  October 9, 2020

• Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment.

  Hendrix N, Regier DA, Chatterjee J, Dhanda DS, Basu A, Veenstra DL, Carlson JJ. Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment. Per Med. 2020 Sep;17(5):389-398. doi: 10.2217/pme-2020-0

  rakerr2

  September 17, 2020

• Association of COVID-19-Related Hospital Use and Overall COVID-19 Mortality in the USA.

  Karaca-Mandic P, Sen S, Georgiou A, Zhu Y, Basu A. Association of COVID-19-Related Hospital Use and Overall COVID-19 Mortality in the USA. J Gen Intern Med. 2020 Aug 19. doi: 10.1007/s11606-020-06084-7. [Epub ahead of print]

  rakerr2

  August 19, 2020

• Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps.

  Yeung K, Barthold D, Dusetzina SB, Basu A. Patient and Plan Spending after State Specialty-Drug Out-of-Pocket Spending Caps. N Engl J Med. 2020 Aug 6;383(6):558-566. doi: 10.1056/NEJMsa1910366.

  rakerr2

  August 6, 2020

• COVID-19 Infection Fatality Rates: The Author Replies.

  Basu A. COVID-19 Infection Fatality Rates: The Author Replies. Health Aff (Millwood). 2020 Aug;39(8):1462-1463. doi: 10.1377/hlthaff.2020.01182.

  rakerr2

  August 1, 2020

• Providers’ perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.

  Bounthavong M, Suh K, Christopher MLD, Veenstra DL, Basu A, Devine EB. Providers’ perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qu

  rakerr2

  August 1, 2020

• Regression Discontinuity Design.

  Maciejewski ML, Basu A. Regression Discontinuity Design. JAMA. 2020 Jul 28;324(4):381-382. doi: 10.1001/jama.2020.3822.

  rakerr2

  July 28, 2020

• Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States.

  Basu A. Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States. Health Aff (Millwood). 2020 Jul;39(7):1229-1236. doi: 10.1377/hlthaff.2020.00455. Epub 2020 May 7.

  rakerr2

  July 1, 2020

• Evidence generation, decision making, and consequent growth in health disparities.

  Basu A, Gujral K. Evidence generation, decision making, and consequent growth in health disparities. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14042-14051. doi: 10.1073/pnas.1920197117. Epub 2020 Jun 8.

  rakerr2

  June 23, 2020

• Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease: Protocol and Baseline Results for a Comparative Effectiveness Study.

  Coleman KJ, Fischer H, Arterburn DE, Barthold D, Barton LJ, Basu A, Courcoulas A, Crawford CL, Fedorka P, Kim B, Mun E, Murali S, Reynolds K, Suh K, Wei R, Yoon TK, Zane R. Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease:

  rakerr2

  April 6, 2020